Development of a Luminex xTAG Assay for the Rapid Detection of Five Aminoglycoside Resistance Genes Both in Staphylococci and Enterococci

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Fengjiao XuPengju Guo

Abstract

Resistance to aminoglycoside antibiotics is now common in pathogenic bacteria, making treatment of infections difficult. The rapid spread of resistance is mainly related to the dissemination of genes encoding aminoglycoside-modifying enzymes (AMEs). Staphylococci and enterococci are opportunistic human pathogens capable of causing a wide range of infections. Isolates from clinical cases are often found to be resistant to aminoglycosides. The aim of the present study was to develop a bead-based xTAG assay for the simultaneous detection of five prevalent aminoglycoside resistance genes in staphylococci and enterococci, including aac(6')-Ie-aph(2″)-Ia, aph(3')-IIIa, ant(4')-Ia, ant(9)-Ia, and ant(6)-Ia. The limit of detection ranged from 10 to 1000 copies/μL of input purified plasmid DNA. Twenty-two bacterial isolates from clinical samples were examined using the newly developed xTAG assay and also by conventional PCR to determine the relative performance of each. The results obtained by xTAG assay showed higher detection rates and accuracy for AME genes than conventional PCR. It indicated that the xTAG-multiplex PCR method is a high-throughput tool for rapid identification of AME genes.

References

Nov 1, 1990·Antimicrobial Agents and Chemotherapy·H OunissiP Courvalin
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·S J KaoJ W Chow
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Sergei B VakulenkoJoseph W Chow
Feb 17, 2009·Methods in Molecular Biology
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky
Nov 6, 2013·Analytical and Bioanalytical Chemistry·Elena PonzoniLaura Morello
Mar 25, 2014·BMC Infectious Diseases·Shamshul AnsariMoti Lal Chapagain
Dec 2, 2014·Nature Reviews. Microbiology·Jessica M A BlairLaura J V Piddock
Mar 15, 2015·International Journal of Environmental Research and Public Health·Wanxiang LiHuoyang Lv
Oct 19, 2017·Bioscience of Microbiota, Food and Health·Yuji Ohashi, Tomohiko Fujisawa
Nov 15, 2017·The Kaohsiung Journal of Medical Sciences·Azar Dokht KhosraviEffat Abbasi Montazeri

❮ Previous
Next ❯

Methods Mentioned

BETA
phosphotransferases
genotyping
PCR
nucleic acid hybridization
flow cytometry
Assay
nucleic acid amplifications
PCRs
electrophoresis

Software Mentioned

Primer
Luminex xPONENT3
BLAST
Primer Premier

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.